Chemical Nameabametapir
Dosage FormLotion, (topical; 0.74%)
Drug ClassMiscellaneous
CompanyGroupe Parima Inc.
Approval Year2020


  • For the topical treatment of head lice infestation in patients 6 months of age and older.
Last updated on 12/7/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Xeglyze (abametapir) Prescribing Information.2020Groupe Parima Inc., Switzerland